|
|
在研机构- |
|
在研适应症- |
|
最高研发阶段无进展 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
A Single Center, Single Arm, Single Dose, Bioavailability Study of EVEGYN 600 Mg/1000 Mg/100 Mg Vaginal Ovule (a Fixed Dose Combination of 600 Mg Fenticonazole Nitrate + 1000 Mg Tinidazole + 100 Mg Lidocaine) in 18 Healthy Female Subjects
A single dose of the study drug will be administered to healthy female subjects in a single period to obtain pharmacokinetic parameters for each active ingredient.
Phase III Study to Evaluate Efficacy and Safety of Different Formulations of Fenticonazole + Tinidazole + Lidocaine in the Treatment of Bacterial Vaginosis, Candidal Vulvovaginitis, Trichomonal Vaginitis and Mixed Infections
Efficacy and safety of two new formulations compared to Gynomax® XL ovule in the treatment of trichomonal vaginitis, bacterial vaginosis, candidal vulvovaginitis and mixed vaginal infections was evaluated in this randomized, three-arms, multicentral study.
100 项与 SCNA x Ergosterol x DNA 相关的临床结果
100 项与 SCNA x Ergosterol x DNA 相关的转化医学
0 项与 SCNA x Ergosterol x DNA 相关的专利(医药)